MEDICAL TRANSCRIPTION BILLING, CORP. (NASDAQ:MTBCP) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective January 1, 2018, Mahmud Haq will assume the role of Executive Chairman of the Board of Directors, Stephen Snyder, MTBC’s President will be appointed CEO and A. Hadi Chaudhry, MTBC’s VP-Global Operations, will be appointed President.

The foregoing description of the change in the senior leadership team does not purport to be complete and is qualified entirely by reference to the Press Release dated December 1, 2017, a copy of which is attached as an exhibit to this Current Report on Form 8-K and is incorporated herein by reference.

(S)

MEDICAL TRANSCRIPTION BILLING, CORP Exhibit
EX-99.1 2 ex99-1.htm   MTBC Announces Senior Leadership Team Promotions   SOMERSET,…
To view the full exhibit click here